Johnson & Johnson's robotic surgery device gets US FDA marketing authorization

جونسون آند جونسون

Johnson & Johnson

JNJ

0.00

- Johnson & Johnson JNJ.N said on Wednesday the U.S. Food and Drug Administration had granted marketing authorization for its Ottava robotic surgical system, clearing the way for the healthcare conglomerate to enter the U.S. soft-tissue robotic surgery market.